Technology News and Research

RSS

Force 3 acquires secureRAD

Force 3, delivering innovative technology solutions, today announced the acquisition of secureRAD, a provider of disruptive technology solutions for the medical imaging industry.

5 Jun 2012

Chatham, Baxter partner to develop and commercialize hemophilia B gene therapy treatment

Baxter International Inc. today announced that it has entered into an exclusive global agreement with Chatham Therapeutics, LLC, an affiliate of Asklepios BioPharmaceutical, Inc. (AskBio), for the development and commercialization of potential treatments for hemophilia B utilizing Chatham's gene therapy technology.

From Baxter International Inc. 5 Jun 2012

FDA approves Arteriocyte’s ACD-A for use with Magellan system

Arteriocyte Medical Systems, Inc. announced today approval by the U.S. Food and Drug Administration (FDA) to manufacture and distribute the Arteriocyte Medical Systems brand of Anticoagulant Citrate Dextrose Solution, USP (ACD-A) for use with its Magellan Platelet Separation System.

5 Jun 2012

New data from ImmunoGen’s SAR3419 Phase I study on CD19+ NHL

ImmunoGen, Inc., a biotechnology company, today announced the presentation of new clinical data for the investigational compound, SAR3419, at the American Society of Clinical Oncology (ASCO) annual meeting taking place in Chicago, IL.

4 Jun 2012

ImmunoGen reports data from T-DM1 Phase III trial on HER2-positive metastatic breast cancer

ImmunoGen, Inc., a biotechnology company with a proprietary Targeted Antibody Payload (TAP) technology, today announced results from the trastuzumab emtansine Phase III EMILIA trial conducted by Roche.

4 Jun 2012

Study shows valuable role of Mammostrat in assessing ER+ postmenopausal breast cancer patients

GE Healthcare today announced results from the Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial at the 2012 Annual Meeting of the American Society of Clinical Oncology.

4 Jun 2012

Scientists propose new theory of the brain activity behind arm movements

Unlike their visual cousins, the neurons that control movement are not a predictable bunch. Scientists working to decode how such neurons convey information to muscles have been stymied when trying to establish a one-to-one relationship between a neuron's behavior and external factors such as muscle activity or movement velocity.

4 Jun 2012

Roche to initiate three studies with T-DM1 for early stage HER2-positive breast cancer

ImmunoGen, Inc., a biotechnology company with a proprietary Targeted Antibody Payload (TAP) technology, today announced that Roche is implementing a "three-pronged approach" to developing trastuzumab emtansine (T-DM1) for early stage HER2-positive breast cancer, according to plans outlined by Roche at its 2012 ASCO analyst event.

4 Jun 2012

Favorable results from CytRx’s INNO-206 Phase 1b/2 trial on soft tissue sarcomas

CytRx Corporation, a biopharmaceutical company specializing in oncology, announces that favorable clinical results from its Phase 1b/2 clinical trial with its tumor-targeting doxorubicin conjugate INNO-206 in patients with advanced solid tumors, primarily soft tissue sarcomas, are being presented today at the American Society of Clinical Oncology (ASCO) conference in Chicago.

4 Jun 2012

New evidence of important role of next-generation sequencing in cancer treatment

Foundation Medicine, Inc., a molecular information company that brings comprehensive cancer genomic analysis to routine clinical care, today announced results from two studies using next-generation sequencing (NGS) to provide actionable information about genomic tumor alterations in individual patients' cancers across all solid tumor types.

2 Jun 2012

Patients with normal lipoprotein(a) levels may retain risk of atherosclerosis due to elevated LDL-P number

LipoScience, Inc., an in vitro diagnostic company advancing patient care by developing high value proprietary clinical diagnostic tests using nuclear magnetic resonance (NMR) technology, today announced results from a clinical study demonstrating that patients with normal levels of lipoprotein(a) may retain significant risk of atherosclerosis due to an elevated low density lipoprotein particle (LDL-P) number.

2 Jun 2012

Researchers uncover fundamental properties of key molecular signaling system using optical tweezers

By using a laser microbeam technology called optical tweezers, UC Irvine and UCLA researchers have uncovered fundamental properties of a key molecular signaling system involved with development, cancer and cardiovascular disease.

2 Jun 2012

Prenatal Imaging Center offers new ultrasound technology with high image clarity

Prenatal Imaging Center, LLC is the only imaging center in the Kansas area to offer HDlive. HDlive is the newest ultrasound technology available and provides extraordinary image clarity. This equipment provides an even more detailed view of baby and womb.

2 Jun 2012

High costs can limit access to potentially life-saving technology

More than one-fifth of people who have received referrals to test for cancer-causing genes say they will only undergo testing if their insurance covers the cost-just as more insurers are instituting cost-sharing for medical services like genetic testing, according to new findings from Fox Chase Cancer Center in Philadelphia released at this year's 2012 Annual Meeting of the American Society of Clinical Oncology on Saturday, June 2.

2 Jun 2012

Engineered proteins demonstrate flu-fighting potency

Computer-designed proteins are under construction to fight the flu. Researchers are demonstrating that proteins found in nature, but that do not normally bind the flu, can be engineered to act as broad-spectrum antiviral agents against a variety of flu virus strains, including H1N1 pandemic influenza.

2 Jun 2012

Akron General Medical Center to install Brainsuite iMRI and iCT integrated neurosurgical suites

Brainlab, a manufacturer of software-driven systems for targeted, less-invasive medical treatments, announced today that Akron General Medical Center will install both Brainsuite iMRI and iCT, making it one of only a handful of hospitals in the world to offer both solutions.

2 Jun 2012

Research roundup: Changing unhealthy diets with mobile tech; ACOs for Medicaid

Multiple Behavior Changes In Diet And Activity -- Mobile technologies have been touted for their potential benefits to health and wellness. Researchers in this study gave 204 individuals a dieting and exercise regimen. They also gave each person a handheld device to record adherence and receive remote coaching.

2 Jun 2012

New web-based cessation program takes smokers from preparation to quit date

StopAdvisor is a new web-based smoking cessation program, which takes smokers from preparation for the target quit date to the quit date itself. It achieves this by offering expert advice through a combination of interactive menus and personalised sessions.

2 Jun 2012

Two pharma companies plan international trials into targeted cancer treatments in the UK

A Cancer Research UK initiative to improve cancer gene testing has prompted two pharmaceutical companies to plan pioneering international trials into targeted cancer treatments in the UK.

2 Jun 2012

IPD connector outperforms negative pressure, split-septum needleless IV connector

InVision-Plus with Neutral Advantage Technology outperformed a negative pressure, split-septum needleless IV connector in a prospective study that examined the association of different IV connector types with catheter-related bloodstream infection (CR-BSI) rates.

2 Jun 2012

Technology News and Research

Force 3 acquires secureRAD

Chatham, Baxter partner to develop and commercialize hemophilia B gene therapy treatment

FDA approves Arteriocyte’s ACD-A for use with Magellan system

New data from ImmunoGen’s SAR3419 Phase I study on CD19+ NHL

ImmunoGen reports data from T-DM1 Phase III trial on HER2-positive metastatic breast cancer

Study shows valuable role of Mammostrat in assessing ER+ postmenopausal breast cancer patients

Scientists propose new theory of the brain activity behind arm movements

Roche to initiate three studies with T-DM1 for early stage HER2-positive breast cancer

Favorable results from CytRx’s INNO-206 Phase 1b/2 trial on soft tissue sarcomas

New evidence of important role of next-generation sequencing in cancer treatment

Patients with normal lipoprotein(a) levels may retain risk of atherosclerosis due to elevated LDL-P number

Researchers uncover fundamental properties of key molecular signaling system using optical tweezers

Prenatal Imaging Center offers new ultrasound technology with high image clarity

High costs can limit access to potentially life-saving technology

Engineered proteins demonstrate flu-fighting potency

Akron General Medical Center to install Brainsuite iMRI and iCT integrated neurosurgical suites

Research roundup: Changing unhealthy diets with mobile tech; ACOs for Medicaid

New web-based cessation program takes smokers from preparation to quit date

Two pharma companies plan international trials into targeted cancer treatments in the UK

IPD connector outperforms negative pressure, split-septum needleless IV connector

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News